Company Overview

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China and internationally. It provides health products, drugs, medical instruments, Chinese medicine resources, and tea. The company offers its products under the Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong brand names. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

  • Name

    Yunnan Baiyao Group Co.,Ltd

  • CEO

    Mr. Ming Dong

  • Website

    www.yunnanbaiyao.com.cn

  • Sector

    Pharmaceuticals

  • Year Founded

    1902

Profile

  • Market Cap

    CN¥90.03B

  • EV

    CN¥75.57B

  • Shares Out

    1,784.26M

  • Revenue

    CN¥39.26B

  • Employees

    8,834

Margins

  • Gross

    27.33%

  • EBITDA

    10.43%

  • Operating

    9.88%

  • Pre-Tax

    13.21%

  • Net

    11.35%

  • FCF

    10.1%

Returns (5Yr Avg)

  • ROA

    7.82%

  • ROTA

    10.76%

  • ROE

    10.6%

  • ROCE

    9.89%

  • ROIC

    13.79%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    CN¥64.58

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    CN¥16.9B

  • Net Debt

    -CN¥14.49B

  • Debt/Equity

    0.06

  • EBIT/Interest

    66.32

Growth (CAGR)

  • Rev 3Yr

    2.61%

  • Rev 5Yr

    7.17%

  • Rev 10Yr

    8.65%

  • Dil EPS 3Yr

    -2.63%

  • Dil EPS 5Yr

    5.83%

  • Dil EPS 10Yr

    3.75%

  • Rev Fwd 2Yr

    6.72%

  • EBITDA Fwd 2Yr

    7.11%

  • EPS Fwd 2Yr

    11.24%

  • EPS LT Growth Est

    10.98%

Dividends

  • Yield

  • Payout

    83.16%

  • DPS

    CN¥2.08

  • DPS Growth 3Yr

    -9.32%

  • DPS Growth 5Yr

    7.77%

  • DPS Growth 10Yr

    24.18%

  • DPS Growth Fwd 2Yr

    5.08%

SZSE:000538